An official website of the United States government
NIH Guide: Weekly Index for November 27, 2020
Weekly NIH Funding Opportunities and Notices
November 27, 2020
Policy Notices
-
RESCINDED - Prohibition on Expending NIH Grant Funds for Covered Telecommunications Equipment or Services
(NOT-OD-21-030)National Institutes of Health
General Notices
-
Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science
(NOT-OD-21-011)National Institutes of HealthNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences ResearchNational Institute on Minority Health and Health Disparities
-
Rollout of Redesigned eRA Commons Home and Landing Screens in January 2021
(NOT-OD-21-028)National Institutes of HealthAgency for Healthcare Research and QualityFood and Drug AdministrationCenters for Disease Control and Prevention
-
Notice of Intent to Reissue Funding Opportunity Announcements "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)" to Permit Resubmissions
(NOT-OD-21-034)NIH Basic Behavioral and Social Science Opportunity NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development
-
Request for Information (RFI) Regarding Opportunities for New National Programs at the National Cancer Institutes (NCI) Frederick National Laboratory for Cancer Research
(NOT-CA-21-018)National Cancer Institute
Notice of Changes to Funding Opportunities
-
Notice of Expiration of PAR-19-370 NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
(NOT-DE-20-034)National Institute of Dental and Craniofacial Research
-
Notice of Clarification to NIEHS' Participation on PA-21-071, "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"
(NOT-ES-21-004)National Institute of Environmental Health Sciences
-
Notice of Change: Clarification of Page Limits for RFA-EY-20-001 "NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed)"
(NOT-EY-21-003)National Eye Institute
-
Notice of Removal of Cost Matching Requirements for RFA-NS-21-010 "HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)"
(NOT-NS-21-016)National Institute of Neurological Disorders and Stroke
-
RESCINDED - Notice of Clarification of SB1 Resubmission/Submission Policy
(NOT-OD-21-027)National Institutes of Health
-
Notice Extending Expiration Date and Adding Receipt Date for PAR-18-307: Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)
(NOT-OD-21-031)Office of Disease PreventionNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Cancer InstituteNational Institute on Drug AbuseNational Center for Complementary and Integrative Health
-
Notice Extending Expiration Date and Adding Receipt Date for PAR-18-324: Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
(NOT-OD-21-032)Office of Disease PreventionNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Cancer InstituteNational Institute on Drug AbuseEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Center for Complementary and Integrative HealthNational Institute on Minority Health and Health Disparities
Notices of Intent to Publish
Notices of Special Interest
-
Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications
(NOT-EB-20-017)National Institute of Biomedical Imaging and BioengineeringNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of General Medical SciencesNational Cancer InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Center for Complementary and Integrative Health
-
Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad)
(NOT-OD-21-035)National Institutes of HealthNational Institute of Dental and Craniofacial ResearchNational Heart, Lung, and Blood Institute
Funding Opportunities
-
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
(PAR-20-309)National Institute on AgingApplication Receipt Date(s): Standard dates apply. The first standard due date for this FOA is February 5, 2021.
-
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
(PAR-21-068)National Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
(PAR-21-069)National Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Not Applicable
-
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
(PAR-21-084)National Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): Standard dates apply. The first standard due date for this FOA is February 16, 2021
-
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)
(RFA-CA-21-001)National Cancer InstituteNational Human Genome Research InstituteApplication Receipt Date(s): March 10, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
(RFA-CA-21-007)National Cancer InstituteApplication Receipt Date(s): February 22, 2021; May 27, 2021; September 29, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
-
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
(RFA-CA-21-008)National Cancer InstituteApplication Receipt Date(s): February 22, 2021; May 27, 2021; September 29, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)
(RFA-CA-21-009)National Cancer InstituteApplication Receipt Date(s): February 22, 2021; May 27, 2021; September 29, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on No late applications will be accepted for this Funding Opportunity Announcement.
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
(RFA-CA-21-010)National Cancer InstituteApplication Receipt Date(s): February 22, 2021; May 27, 2021; September 29, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). No late applications will be accepted for this Funding Opportunity Announcement..
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
(RFA-CA-21-011)National Cancer InstituteApplication Receipt Date(s): February 22, 2021; May 27, 2021; Sept 29, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). No late applications will be accepted for this Funding Opportunity Announcement.
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
(RFA-CA-21-012)National Cancer InstituteApplication Receipt Date(s): February 22, 2021; May 27, 2021; September 29, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). No late applications will be accepted for this Funding Opportunity Announcement
-
GenitoUrinary Development Molecular Anatomy Project (GUDMAP) - Atlas Projects (U01 Clinical Trial Not Allowed)
(RFA-DK-20-013)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): February 18, 2021
-
Reconfiguration of GenitoUrinary Development Molecular Anatomy Project (GUDMAP) /(Re)Building A Kidney (RBK) Data Hub (U24 Clinical Trial Not Allowed)
(RFA-DK-20-014)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): February 18, 2021
-
Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-NS-21-004)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): March 9, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
-
Small Vessel VCID Biomarker Validation Consortium Sites (U01)(Clinical Trials Not Allowed)
(RFA-NS-21-005)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): March 9, 2021 No late applications will be accepted for this Funding Opportunity Announcement
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: January 14, 2025
For technical issues E-mail OER Webmaster